People · Operator
Named in public records as an officer, director or promoter · active 2014–2018 · Biotechnology, Biotech / Pharma
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Batu Biologics, Inc. | — | Biotechnology | Pre-Seed | $958K | $28.0M | 2014 |
| Therapeutic Solutions International, Inc. | — | Biotech / Pharma | Pre-Seed | $200K | $5.1M | 2018 |
Thomas E Ichim at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Thomas E Ichim on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| TIMOTHY G DIXON | 1 | 1 |
| GERRY B BERG | 1 | 1 |
| Samuel C Wagner | 1 | 1 |
| Dimitrios Nikolaos Theofilopoulos | 1 | 1 |
| Alan Nikolaos Lewis | 1 | 1 |
| Vladimir Nikolaos Bogin | 1 | 1 |
| John Nikolaos Chiplin | 1 | 1 |
| Gerry Nikolaos Berg | 1 | 1 |
| Hong Nikolaos Ma | 1 | 1 |
| John Nikolaos Peck | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.